Neoadjuvant Treatment of Early Triple-negative Breast Cancer With Chidamide and Chemotherapy
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: Chidamide in combination with chemotherapy
Sponsor: Tianjin Medical University Cancer Institute and Hospital